Kenneth Sim's Insider Trades & SAST Disclosures
Kenneth Sim's most recent trade in Bunge Ltd. was a trade of 18 Common Stock done at an average price of $71.8 . Disclosure was reported to the exchange on March 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kenneth Sim.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 71.83 per share. | 04 Mar 2025 | 18 | 6,714 (0%) | 0% | 71.8 | 1,293 | Common Stock |
| Astrana Health Inc. | Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 15 Feb 2025 | 699,896 | 6,132,802 (11%) | 1% | 0 | Common Stock | |
| Astrana Health Inc. | Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 15 Feb 2025 | 26,232 | 546,349 (1%) | 0% | 0 | Common Stock | |
| Bunge Ltd. | M. Kenneth Simril | Director | Grant, award, or other acquisition of securities at price $ 88.60 per share. | 02 Dec 2024 | 15 | 6,696 (0%) | 0% | 88.6 | 1,329 | Common Stock |
| Astrana Health Inc. | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.65 per share. | 18 Nov 2024 | 28,046 | 609,905 (1%) | 0% | 18.7 | 523,058 | Common Stock |
| Astrana Health Inc. | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 28,046 | 0 | - | - | Stock option (right to buy) | |
| Astrana Health Inc. | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 133,333 | 581,859 (1%) | 0% | 0 | Common Stock | |
| Astrana Health Inc. | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 66,667 | 448,526 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 100.92 per share. | 02 Sep 2024 | 13 | 6,681 (0%) | 0% | 100.9 | 1,312 | Common Stock |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 107.33 per share. | 03 Jun 2024 | 12 | 6,668 (0%) | 0% | 107.3 | 1,288 | Common Stock |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 1,947 | 6,656 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd. | Kenneth M. Simril | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.06 per share. | 11 May 2024 | 302 | 4,709 (0%) | 0% | 105.1 | 31,728 | Common Stock |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 93.69 per share. | 01 Mar 2024 | 16 | 5,011 (0%) | 0% | 93.7 | 1,499 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 351,859 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 381,859 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Sim Kenneth | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 321,859 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 114.92 per share. | 01 Sep 2023 | 12 | 4,982 (0%) | 0% | 114.9 | 1,379 | Common Stock |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 92.13 per share. | 02 Jun 2023 | 15 | 4,970 (0%) | 0% | 92.1 | 1,382 | Common Stock |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 2,229 | 4,955 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 96.42 per share. | 02 Mar 2023 | 12 | 2,726 (0%) | 0% | 96.4 | 1,157 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 08 Dec 2022 | 51,445 | 243,272 (0%) | 0% | 10 | 514,450 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 51,445 | 0 | - | - | Warrants to purchase Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.00 per share. | 08 Dec 2022 | 48,587 | 291,859 (0%) | 0% | 11 | 534,457 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 48,587 | 0 | - | - | Warrants to purchase Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 984,042 | 10,191,660 (19%) | 1% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 37,439 | 520,117 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 96.50 per share. | 02 Dec 2022 | 12 | 2,714 (0%) | 0% | 96.5 | 1,158 | Common Stock |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 100.09 per share. | 02 Sep 2022 | 11 | 2,702 (0%) | 0% | 100.1 | 1,101 | Common Stock |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 114.62 per share. | 02 Jun 2022 | 8 | 2,691 (0%) | 0% | 114.6 | 917 | Common Stock |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 1,842 | 2,683 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 107.25 per share. | 02 Mar 2022 | 4 | 841 (0%) | 0% | 107.3 | 429 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 392,816 | 0 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 392,816 | 0 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 258,824 | 230,576 (0%) | 0% | 0 | Common Stock | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 19,227 | 104,180 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 19,227 | 0 | - | - | Performance RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.34 per share. | 19 Feb 2022 | 12,214 | 97,518 (0%) | 0% | 162.3 | 1,982,821 | Common Stock, $0.01 Par Value |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 8,546 | 84,953 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 8,546 | 0 | - | - | Performance RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 2,248 | 106,428 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 2,248 | 0 | - | - | Time RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,697 | 109,732 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,697 | 3,396 | - | - | Time RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,607 | 108,035 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,607 | 1,607 | - | - | Time RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 6,940 | 6,940 | - | - | Performance RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 5,998 | 5,998 | - | - | Time RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 4,762 | 4,762 | - | - | Performance RSUs | |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 85.80 per share. | 02 Dec 2021 | 5 | 837 (0%) | 0% | 85.8 | 429 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2021 | 230,688 | 397,724 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 65,242 | 191,827 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 29,502 | 29,502 | - | - | Stock Option (right to buy) | |
| Bunge Ltd. | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 88.47 per share. | 25 Oct 2021 | 832 | 832 (0%) | 0% | 88.5 | 73,603 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 30 Mar 2021 | 31,756 | 859,101 (1%) | 0% | 10 | 317,560 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 31,756 | 0 | - | - | Warrant to Purchase Common Stock | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 150.77 per share. | 09 Mar 2021 | 6,000 | 76,407 (0%) | 0% | 150.8 | 904,614 | Common Stock, $0.01 Par Value |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 21,931 | 90,028 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 21,931 | 0 | - | - | Performance RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 164.90 per share. | 19 Feb 2021 | 13,988 | 82,407 (0%) | 0% | 164.9 | 2,306,621 | Common Stock, $0.01 Par Value |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 9,504 | 68,097 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 9,504 | 0 | - | - | Performance RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,513 | 92,541 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,513 | 0 | - | - | Time RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,248 | 94,789 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,248 | 2,248 | - | - | Time RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 1,606 | 3,214 | - | - | Time RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 1,606 | 96,395 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 7,912 | 7,912 | - | - | Performance RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 5,159 | 5,159 | - | - | Performance RSUs | |
| Crown Castle Inc | Kenneth J. Simon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 5,093 | 5,093 | - | - | Time RSUs | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 185,938 | 827,344 (1%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 22 Dec 2020 | 31,756 | 859,100 (1%) | 0% | 10 | 317,560 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 65,242 | 126,585 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 29,502 | 29,502 | - | - | Stock Option (right to buy) | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 17.23 per share. | 14 Sep 2020 | 5,000 | 42,996 (0%) | 0% | 17.2 | 86,168 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 17.20 per share. | 14 Sep 2020 | 1,000 | 17,379 (0%) | 0% | 17.2 | 17,204 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 17.60 per share. | 10 Sep 2020 | 5,000 | 37,996 (0%) | 0% | 17.6 | 88,000 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Other type of transaction at price $ 0.00 per share. | 09 Sep 2020 | 564,706 | 641,407 (1%) | 1% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Other type of transaction at price $ 0.00 per share. | 09 Sep 2020 | 564,706 | 564,706 (1%) | 1% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 18.34 per share. | 27 Aug 2020 | 5,000 | 1,770,556 (3%) | 0% | 18.3 | 91,700 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges